HAISHUN(SZ:300501) Xin Lang Cai Jing·2025-10-30 11:15Core Insights - Haishun New Materials is a leading enterprise in the high-barrier packaging materials sector directly in contact with pharmaceuticals, established in 2005 and listed on the Shenzhen Stock Exchange in 2016 [1] Group 1: Business Performance - In Q3 2025, Haishun New Materials achieved a revenue of 823 million yuan, ranking first among six companies in the industry, with the second-ranked Tianyuan Co. generating 767 million yuan [2] - The revenue from new pharmaceutical packaging materials was 495 million yuan, accounting for 89.58% of total revenue, while other business revenue was 57.5 million yuan, making up 10.42% [2] - The net profit for the same period was 54.42 million yuan, placing the company second in the industry, with the first being Jinghua Laser at 73.13 million yuan [2] Group 2: Financial Ratios - As of Q3 2025, the asset-liability ratio for Haishun New Materials was 38.56%, higher than the previous year's 34.82% and above the industry average of 37.97% [3] - The gross profit margin was 22.93%, down from 29.69% year-on-year but still above the industry average of 14.09% [3] Group 3: Shareholder Information - As of September 30, 2025, the number of A-share shareholders decreased by 12.81% to 13,500, while the average number of circulating A-shares held per account increased by 14.69% to 9,274.86 [5] - The top ten circulating shareholders included a new entrant, the Medical Device ETF (159883), holding 717,800 shares [5] Group 4: Executive Compensation - The chairman and general manager, Lin Wuhui, received a salary of 912,300 yuan in 2024, a slight increase from 912,000 yuan in 2023 [4]